#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13380	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2196	607.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1778	1778	T	796	T	729	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13380	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2196	607.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	768	C,T	710,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25136	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3563	703.5	0	.	n	.	0	T695C	SNP	695	695	T	1007	1007	C	763	C	713	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25136	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3563	703.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1649	1649	A	792	A,G	737,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25136	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3563	703.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2283	2283	C	804	C,T	738,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25136	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3563	703.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2357	2357	A	848	A	779	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25136	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3563	703.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2909	2909	C	800	C	739	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1820	folP	855	855	100.0	folP.l15.c30.ctg.1	1632	111.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1037	1039	AGC	190;190;190	A;G;C	179;178;176	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5144	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3430	149.6	1	SNP	p	S91F	1	.	.	271	273	TTC	593	595	TTC	173;173;174	T;T;C	165;164;165	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5144	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3430	149.6	1	SNP	p	D95G	1	.	.	283	285	GGC	605	607	GGC	162;162;162	G;G;C	152;152;150	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5144	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3430	149.6	1	SNP	p	G95N	0	.	.	283	285	GGC	605	607	GGC	162;162;162	G;G;C	152;152;150	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1494	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1339	111.3	1	SNP	p	G45D	0	.	.	133	135	GGC	539	541	GGC	199;202;198	G;G;C	188;190;184	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	750	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1010	74.1	0	.	n	.	0	A197.	DEL	197	197	A	630	630	A	193	A	172	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4904	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3009	162.7	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	188;186;184	G;A;C	172;168;170	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4904	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3009	162.7	1	SNP	p	R87W	0	.	.	259	261	CGT	596	598	CGT	185;184;184	C;G;T	172;172;171	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4904	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3009	162.7	1	SNP	p	R87I	0	.	.	259	261	CGT	596	598	CGT	185;184;184	C;G;T	172;172;171	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4904	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3009	162.7	1	SNP	p	S87R	1	.	.	259	261	CGT	596	598	CGT	185;184;184	C;G;T	172;172;171	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4904	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3009	162.7	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	184;182;181	T;C;C	168;170;168	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3954	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2467	159.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1432	1434	GGC	200;197;196	G;G;C	186;183;183	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1259	1261	GCA	226;228;230	G;C;A	212;213;218	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1262	1264	ATC	230;236;240	A;T;C	217;221;222	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1274	1276	GTG	235;237;240	G;T;G	222;221;226	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1274	1276	GTG	235;237;240	G;T;G	222;221;226	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1778	1780	ACC	183;183;184	A;C;C	164;168;169	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1832	1834	GCG	183;186;183	G;C;G	166;149;152	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1832	1834	GCG	183;186;183	G;C;G	166;149;152	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1955	1957	AGC	165;166;170	A;G;C	151;154;155	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1964	1966	GGC	168;169;171	G;G;C	151;152;153	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3660	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2469	147.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1982	1984	CCG	150;154;157	C,G;C,G;G	97,5;101,1;104	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5266	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3077	170.8	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1513	1515	ACG	177;180;180	A;C,T;G	164;165,1;166	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5266	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3077	170.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	208;209;205	C;C;G	186;195;189	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2232	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1889	117.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	167	C	156	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2512	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1702	147.0	0	.	p	.	0	Q143R	NONSYN	427	429	CAA	694	696	CGA	209;207;205	C;G;A	197;194;189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2512	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1702	147.0	1	SNP	p	G120K	1	.	.	358	360	AAG	625	627	AAG	223;222;221	A;A;G	198;200;196	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2512	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1702	147.0	1	SNP	p	N121D	0	.	.	361	363	AAC	628	630	AAC	221;220;220	A,G;A;C	198,1;199;199	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2512	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1702	147.0	1	SNP	p	A121N	1	.	.	361	363	AAC	628	630	AAC	221;220;220	A,G;A;C	198,1;199;199	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9330	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4900	190.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1032	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1055	97.5	1	SNP	p	V57M	1	.	.	169	171	ATG	581	583	ATG	202;207;205	A;T;G	185;190;189	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
